(CN) – The European Commission fined Johnson & Johnson and Novartis a combined $22.4 million for conspiring to keep a generic version of the painkiller fentanyl – 100 times more potent than morphine – off the EU market in exchange for “a part of the cake.”
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.

